Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.83M Sell
4,331
-28
-0.6% -$11.2K 0.53% 59
2026
Q2
$1.58M Buy
+4,359
New +$1.49M 0.46% 67
2023
Q3
– Sell
-5,912
Closed -$1.31M – 116
2023
Q2
$1.31M Buy
+5,912
New +$1.37M 0.63% 58
2018
Q1
– Sell
-17,616
Closed -$3.06M – 193
2017
Q4
$3.06M Buy
+17,616
New +$3.12M 2.25% 22

Other funds holding AMGN

G&S Capital's AMGN Position: Q3 2026 in Review

G&S Capital reduced its Amgen (AMGN) stake by 0.64% in Q3 2026, selling an estimated $11.2K and leaving 4,331 shares worth $1.83M. The position accounts for 0.53% of the portfolio, ranked #59.

G&S Capital first reported a position in AMGN in Q4 2017 and has held it in 4 quarters since. The position peaked at $3.06M in Q4 2017. 2,617 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • G&S Capital held 4,331 shares of Amgen worth $1.83M as of Q3 2026.
  • G&S Capital sold 28 Amgen shares in Q3 2026, an estimated $11.2K.
  • Amgen made up 0.53% of G&S Capital's portfolio in Q3 2026, its #59 holding.
  • G&S Capital first reported a position in Amgen in Q4 2017 and has held it in 4 quarters since.
  • G&S Capital's Amgen position peaked at $3.06M in Q4 2017.
  • 2,617 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on G&S Capital's 13F filing for Q3 2026, filed 23 Oct 2026.